John Chalmers
Director/Board Member at Prognomix, Inc.
Profile
John Chalmers is currently a Director at Prognomix, Inc. He previously held positions as Chairman & President at National Health & Medical Research Council and International Society of Hypertension, Principal at Royal Prince Alfred Hospital and Massachusetts Institute of Technology.
He received a doctorate degree from The University of New South Wales in 1967 and an undergraduate degree from The University of Sydney in 1963.
John Chalmers active positions
| Companies | Position | Start |
|---|---|---|
Prognomix, Inc.
 Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Director/Board Member | - |
Former positions of John Chalmers
| Companies | Position | End |
|---|---|---|
International Society of Hypertension
 International Society of Hypertension Miscellaneous Commercial ServicesCommercial Services The International Society of Hypertension (ISH) was established in 1966 and is committed to promoting and encouraging the advancement of hypertension research. The non-profit company is based in Hampton Hill, UK. The ISH Women in Hypertension Research Committee focuses on improving care for women with hypertension worldwide. Professor Bryan Williams has been announced as the next President of the ISH for the years 2022-2024. | Chairman | - |
Royal Prince Alfred Hospital
 Royal Prince Alfred Hospital Hospital/Nursing ManagementHealth Services Royal Prince Alfred Hospital provides general medical and surgical services. The company was founded in 1882 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
| National Health & Medical Research Council | Chairman | - |
| Massachusetts Institute of Technology | Corporate Officer/Principal | - |
Training of John Chalmers
| The University of New South Wales | Doctorate Degree |
| The University of Sydney | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Royal Prince Alfred Hospital
Royal Prince Alfred Hospital Hospital/Nursing ManagementHealth Services Royal Prince Alfred Hospital provides general medical and surgical services. The company was founded in 1882 and is headquartered in Sydney, Australia. | Health Services |
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Health Technology |
| National Health & Medical Research Council | Government |
International Society of Hypertension
International Society of Hypertension Miscellaneous Commercial ServicesCommercial Services The International Society of Hypertension (ISH) was established in 1966 and is committed to promoting and encouraging the advancement of hypertension research. The non-profit company is based in Hampton Hill, UK. The ISH Women in Hypertension Research Committee focuses on improving care for women with hypertension worldwide. Professor Bryan Williams has been announced as the next President of the ISH for the years 2022-2024. | Commercial Services |
- Stock Market
- Insiders
- John Chalmers
